# Shuttle Pharmaceuticals Holdings, Inc.: Form 8-K, filed May 1, 2026

- Company: [Shuttle Pharmaceuticals Holdings, Inc.](/companies/shph.md) (CIK 1757499)
- Form: 8-K
- Filed: 2026-05-01
- Accepted by EDGAR: May 1, 2026, 09:23 ET
- Period: 2026-04-30
- Accession: 0001493152-26-020830
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1757499/000149315226020830/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1757499/000149315226020830/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1757499/000149315226020830/form8-k.htm

Filed May 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-020830. Last ingested by Listed: Nov 6, 2026, 18:28 ET. No prices; not investment advice.